AVA-291 is a novel testosterone formulation for women, designed to resist aromatization and reduce breast cancer risk. Data shows AVA-291 has a 1,000-fold lower potential to stimulate breast cancer ...

Pedro F.S. Freitas, MD, recaps his talk at the 2026 Desai Sethi Urology Institute Urology on the Beach meeting. In an interview at the 2026 Desai Sethi Urology Institute Urology on the Beach meeting, ...

The decline in total testosterone was observed even among men with normal body mass index. From 1999 to 2016, testosterone levels have declined in adolescent and young adult men (AYA), according to ...

Break Wave lithotripsy device uses low-pressure ultrasound to fragment kidney stones non-invasively, requiring no anesthesia. The device offers a new treatment option for symptomatic and asymptomatic ...

In this episode of Pearls and Perspectives, host Amy Pearlman, MD, sits down with Ariana L. Smith, MD, to explore how clinicians navigate evidence gaps, evolving guidelines, and emerging innovation in ...

The prospective registry is evaluating a personalized counseling and monitoring strategy for patients who are at an increased risk of prostate cancer due to positive family history or pathogenic ...

Enolen is currently under investigation in a phase 1 trial to assess its safety and efficacy in delivering enzalutamide locally into the prostate.

Jansen underscores the need for urologists to go beyond symptom treatment and focus on identifying root causes of testosterone deficiency. Robert Jansen, MD, emphasizes that all TRT delivery methods ...

Cycling has multiple benefits, and steps can be taken to prevent genitourinary injury. Bicycling across the globe is increasing as a means of exercise and transportation. Clinicians need to be ...

Dr Hamstra describes the three FDA-approved rectal spacers SpaceOAR, Barrigel, and BioProtect, noting differences in placement technique, advantages, potential risks, and the need for long-term ...

Researchers at the Mayo Clinic report that they have developed a legitimate penile traction therapy device for men with Peyronie’s disease that may work when used for just 30 to 90 minutes daily.

In a retrospective study of almost 500 men, the use of hyaluronic acid filler for penile girth enhancement appeared safe with limited adverse events. Using the PhalloFILL system, a novel hyaluronic ...